This document is a Corrigendum (a formal correction) for the research article titled "Signal Transducer and Activator of Transcription 3 Hyperactivation Associates With Follicular Helper T Cell Differentiation and Disease Activity in Rheumatoid Arthritis," originally published in Frontiers in Immunology in 2018.
TL;DR
This update corrects a figure duplication error in a study investigating the role of STAT3 signaling in Rheumatoid Arthritis (RA). The corrected data confirms that among various T cell subsets, only Follicular Helper T (Tfh) cells show a significant positive correlation with clinical disease activity.
What Problem Does This Paper Address?
The original research sought to understand the immunological drivers of Rheumatoid Arthritis (RA), specifically focusing on how the hyperactivation of the STAT3 (Signal Transducer and Activator of Transcription 3) pathway influences the differentiation of Follicular Helper T (Tfh) cells. Tfh cells are critical for B cell activation and antibody production, which are central to RA pathogenesis.
This specific corrigendum addresses a technical error in the original publication's Figure 2. During figure preparation, the authors mistakenly duplicated the scatter plot for Th1 cells into the panel intended for Th2 cells. This document provides the correct Th2 data to ensure the scientific record accurately reflects the relationship between different T cell subsets and disease severity.
Methods
While the full methodology is detailed in the original 2018 paper, the corrigendum highlights the following approaches used to generate the corrected Figure 2:
- Clinical Assessment: Disease activity in RA patients was measured using the DAS28 (Disease Activity Score-28), a standard clinical index.
- Cellular Analysis: Peripheral blood mononuclear cells (PBMCs) were collected from patients, and CD4+ T cell subsets (Naive, Treg, Th1, Th2, Th17, and Tfh) were quantified, likely via flow cytometry.
- Statistical Analysis: The relationship between the frequency of these T cell subsets and DAS28 scores was determined using Spearman’s correlation coefficient ($r$).
Datasets
The study utilized clinical data and biological samples (PBMCs) from a cohort of patients diagnosed with Rheumatoid Arthritis. The exact sample size is not explicitly stated in the corrigendum, though the scatter plots indicate a cohort of approximately 35–40 patients.
Key Insights and Ideas
- Tfh Specificity: The most critical "aha moment" reinforced by the corrected figure is the specificity of the Tfh subset. While RA involves a complex milieu of immune cells, the frequency of Tfh cells ($r=0.49, p=0.005$) is a much stronger indicator of disease activity than other subsets like Th1, Th2, or Th17.
- Validation of Original Conclusions: The authors emphasize that the corrected Th2 data ($r=0.10, p=0.60$) remains statistically non-significant. This confirms that the original error—while a mistake in data presentation—did not lead to false scientific claims regarding the unique importance of Tfh cells in this context.
Key Results
The corrected Figure 2 provides a comparative look at how different T cell percentages correlate with the DAS28 score:
- Tfh Cells: Showed a significant positive correlation ($r=0.49, p=0.005$).
- Th2 Cells (Corrected): Showed no significant correlation ($r=0.10, p=0.60$).
- Other Subsets: Naive T cells, Tregs, Th1, and Th17 cells all showed near-zero correlation coefficients (ranging from $r=-0.02$ to $0.07$) with $p$-values well above the significance threshold ($p > 0.70$).
Limitations and Future Work
The corrigendum itself does not discuss broader limitations or future directions, as its primary purpose is to rectify a specific graphical error. However, the authors note that the correction does not change the scientific conclusions of the original study, which pointed toward STAT3-driven Tfh differentiation as a potential therapeutic target in RA.
Summary updated